2 news items
Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan
RYTM
22 Feb 24
a cohort of 12 Japanese patients to the ongoing trial and, pending completion of the trial, to use these data as part of the Company's registration package
Earnings Scheduled For February 22, 2024
KYMR
L
LASR
22 Feb 24
Packaging (NYSE:AMBP) is likely to report quarterly earnings at $0.04 per share
- Prev
- 1
- Next